Occupational exposure to severe acute respiratory coronavirus virus 2 (SARS-CoV-2) and risk of infection among healthcare personnel

被引:11
|
作者
Shah, Vishal P. [1 ,2 ]
Breeher, Laura E. [1 ,3 ]
Alleckson, Julie M. [3 ]
Rivers, David G. [3 ]
Wang, Zhen [2 ]
Stratton, Emily R. [1 ]
Farah, Wigdan [1 ]
Hainy, Caitlin M. [3 ]
Swift, Melanie D. [1 ,3 ]
机构
[1] Mayo Clin, Div Prevent Occupat & Aerosp Med, Rochester, MN 55905 USA
[2] Mayo Clin, Evidence Based Practice Res Program, Rochester, MN 55905 USA
[3] Mayo Clin, Occupat Hlth Serv, Rochester, MN USA
关键词
COVID-19; WORKERS;
D O I
10.1017/ice.2021.533
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: To assess the rate and factors associated with healthcare personnel (HCP) testing positive for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) after an occupational exposure. Design: Retrospective cohort study. Setting: Academic medical center with sites in Minnesota, Wisconsin, Arizona, and Florida. Participants: HCP with a high or medium risk occupational exposure to a patient or other HCP with SARS-CoV-2. Methods: We reviewed the records of HCP with significant occupational exposures from March 20, 2020, through December 31, 2020. We then performed regression analysis to assess the impact of demographic and occupational variables to assess their impact on the likelihood of testing positive for SARS-CoV-2. Results: In total, 2,253 confirmed occupational exposures occurred during the study period. Employees were the source for 57.1% of exposures. Overall, 101 HCP (4.5%) tested positive in the postexposure period. Of these, 80 had employee sources of exposure and 21 had patient sources of exposure. The postexposure infection rate was 6.2% when employees were the source, compared to 2.2% with patient sources. In a multivariate analysis, occupational exposure from an employee source had a higher risk of testing positive compared to a patient source (odds ratio [OR], 3.22; 95% confidence interval [CI], 1.72-6.04). Sex, age, high-risk exposure, and HCP role were not associated with an increased risk of testing positive. Conclusions: The risk of acquiring coronavirus disease 2019 (COVID-19) following a significant occupational exposure has remained relatively low, even in the prevaccination era. Exposure to an infectious coworker carries a higher risk than exposure to a patient. Continued vigilance and precautions remain necessary in healthcare settings.
引用
收藏
页码:1785 / 1789
页数:5
相关论文
共 50 条
  • [41] Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission Among Air Passengers in China
    Hu, Maogui
    Wang, Jinfeng
    Lin, Hui
    Ruktanonchai, Corrine W.
    Xu, Chengdong
    Meng, Bin
    Zhang, Xin
    Carioli, Alessandra
    Feng, Yuqing
    Yin, Qian
    Floyd, Jessica R.
    Ruktanonchai, Nick W.
    Li, Zhongjie
    Yang, Weizhong
    Tatem, Andrew J.
    Lai, Shengjie
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : E234 - E240
  • [42] Persistent infection with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in a patient with untreated human immunodeficiency virus (HIV)
    Zhabokritsky, Alice
    Mubareka, Samira
    Kozak, Robert A.
    Maguire, Finlay
    Yip, Lily
    Yip, Paul
    Powis, Jeff
    INFECTION CONTROL & HOSPITAL EPIDEMIOLOGY, 2023, 44 (02) : 350 - 351
  • [43] Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare workers with differing levels of coronavirus disease 2019 (COVID-19) patient exposure
    Hunter, Benton R.
    Dbeibo, Lana
    Weaver, Christopher S.
    Beeler, Cole
    Saysana, Michele
    Zimmerman, Michelle K.
    Weaver, Lindsay
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2020, 41 (12): : 1441 - 1442
  • [44] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is likely to be androgen mediated
    Wambier, Carlos Gustavo
    Goren, Andy
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (01) : 308 - 309
  • [45] The emerging role of microRNAs in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
    Mirzaei, Rasoul
    Mahdavi, Farzad
    Badrzadeh, Fariba
    Hosseini-Fard, Seyed Reza
    Heidary, Maryam
    Jeda, Ali Salimi
    Mohammadi, Tayeb
    Roshani, Mahdane
    Yousefimashouf, Rasoul
    Keyvani, Hossein
    Darvishmotevalli, Mohammad
    Sani, Melika Zarei
    Karampoor, Sajad
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 90
  • [46] The severe acute respiratory syndrome due to coronavirus 2 (SARS-CoV-2) infection and the climacteric woman
    Chedraui, Peter
    Perez-Lopez, Faustino R.
    CLIMACTERIC, 2020, 23 (06) : 525 - 527
  • [47] Effect of severe acute respiratory coronavirus virus 2 (SARS-CoV-2 ) mRNA vaccination in healthcare workers with high-risk coronavirus disease 2019 (COVID-19) exposure
    Selby, Laura M.
    Hewlett, Angela L.
    Cawcutt, Kelly A.
    Wood, Macy G.
    Balfour, Teresa L.
    Rupp, Mark E.
    Starlin, Richard C.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2021, 42 (10): : 1281 - 1282
  • [48] Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in vaginal swabs of women with acute SARS-CoV-2 infection: a prospective study
    Schwartz, A.
    Yogev, Y.
    Zilberman, A.
    Alpern, S.
    Many, A.
    Yousovich, R.
    Gamzu, R.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2021, 128 (01) : 97 - 100
  • [49] Mass severe acute respiratory coronavirus 2 (SARS-CoV-2) testing of asymptomatic healthcare personnel (vol 42, pg 625, 2021)
    Roberts, Scott C.
    Peaper, David R.
    Thorne, Craig D.
    Sussman, L. Scott
    Murray, Thomas S.
    Choi, Steven J.
    Pettker, Christian M.
    Russi, Mark B.
    Martinello, Richard A.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2022, 43 (09): : 1312 - 1312
  • [50] Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection: let the virus be its own demise
    Nemunaitis, John
    Stanbery, Laura
    Senzer, Neil
    FUTURE VIROLOGY, 2020, 15 (06) : 381 - 395